Epidemiological characteristics of the influenza pandemic (H1N1) 2009 in Germany based on the mandatory notification of cases;Epidemiologischer Steckbrief der pandemischen Influenza (H1N1) 2009 basierend auf Einzelfallmeldungen nach Infektionsschutzgesetz

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 53, Issue 12, 2010, Pages 1223-1230

  Buda, S ^a   Kopke K ^a   Haas, W ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Epidemiology; Immunosuppression; Pandemics; Risk factors; SurvNet

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A H1N1; MALE; MANDATORY REPORTING; METHODOLOGY; MIDDLE AGED; PANDEMIC; PRESCHOOL CHILD; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; STATISTICS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE NOTIFICATION; FEMALE; GERMANY; HUMANS; INCIDENCE; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MANDATORY REPORTING; MIDDLE AGED; PANDEMICS; POPULATION SURVEILLANCE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 79954441457     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-010-1158-0     Document Type: Article

References (29)

1. Smith GJ, Vijaykrishna D, Bahl J et al (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122–1125
2. Hancock K, Veguilla V, Lu X et al (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361:1945–1952
3. CDC (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 58:521–524
4. Capua I, Kajaste-Rudnitski A, Bertoli E, Vicenzi E (2009) Pandemic vaccine preparedness – have we left something behind? PLoS Pathog 5:e1000482
5. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931–939
6. Poon LL, Chan KH, Smith GJ et al (2009) Molecular detection of a novel human influenza (H1N1) of pandemic potential by conventional and real-time quantitative RT-PCR assays. Clin Chem 55:1555–1558
7. Schulze M, Nitsche A, Schweiger B, Biere B (2010) Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR. PLoS One 5:e9966
8. Bell DM, Weisfuse IB, Hernandez-Avila M et al (2009) Pandemic influenza as 21st century urban public health crisis. Emerg Infect Dis 15:1963–1969
9. Fraser C, Donnelly CA, Cauchemez S et al (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324:1557–1561
10. Donaldson LJ, Rutter PD, Ellis BM et al (2009) Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 339:b5213
11. Presanis AM, De AD, Hagy A et al (2009) The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 6:e1000207
12. Poggensee G, Gilsdorf A, Buda S et al (2010) The first wave of pandemic influenza (H1N1) 2009 in Germany: from initiation to acceleration. BMC Infect Dis 10:155
13. Gilsdorf A, Poggensee G (2009) Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill 14:19318
14. Influenza Investigationsteam des RKI (2009) Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April–16 June 2009. Euro Surveill 14:19295
15. Robert Koch-Institut (2009) Modifikationsmöglichkeiten der Strategie zur Bekämpfung/Eindämmung der Neuen Influenza A/H1N1 in Deutschland in Abhängigkeit von der Entwicklung der Ausbreitung und der Schwere der Erkrankungen. Epidemiol Bull 259–262
16. Robert Koch-Institut (2010) Influenza. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2009. S 111–124
17. Suess T, Buchholz U, Dupke S et al (2010) Shedding and transmission of novel influenza virus A/H1N1 infection in households – Germany, 2009. Am J Epidemiol 171:1157–1164
18. Bautista E, Chotpitayasunondh T, Gao Z et al (2010) Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362:1708–1719
19. Miller E, Hoschler K, Hardelid P et al (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375:1100–1108
20. Ikonen N, Strengell M, Kinnunen L et al (2010) High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 15:19478
21. WHO (2009) Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 84:481–484
22. Krause G, Buchholz U (2010) Rückblick: Epidemiologie und Infektionsschutz im zeitlichen Verlauf der Influenzapandemie (H1N1) 2009. Epidemiol Bull 21:191–197
23. Baker MG, Wilson N, Huang QS et al (2009) Pandemic influenza A(H1N1)v in New Zealand: the experience from april to august 2009. Euro Surveill 14:19319
24. Gomez J, Munayco C, Arrasco J et al (2009) Pandemic influenza in a southern hemisphere setting: the experience in Peru from may to september, 2009. Euro Surveill 14:19371
25. Kunisaki KM, Janoff EN (2009) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9:493–504
26. Casper C, Englund J, Boeckh M (2010) How I treat influenza in patients with hematologic malignancies. Blood 115:1331–1342
27. Wilking H, Buda S, Lippe E von der et al (2010) Mortality of pandemic (H1N1) 2009 influenza in Germany. Euro Surveill (eingereicht)
28. Krause G, Gilsdorf A, Becker J et al (2010) First exchange of experiences concerning the H1N1 pandemic in Germany 2009/2010: report on a workshop held March 22–23, 2010, in Berlin. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 53:510–519
29. Murray CJ, Lopez AD, Chin B et al (2006) Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis. Lancet 368:2211–2218